Teva Pharmaceutical Industries Ltd., being an Israel-based company, is directly impacted by the geopolitical tensions between Israel and Iran. Such tensions can lead to market uncertainty and risk aversion among investors, particularly affecting stocks with significant operations or headquarters in the involved regions. This situation has led to a decrease in TEVA's stock price as investors react to the increased risks.